M4MM
Vireo Growth Closes Colorado Retail Deal, Secures Bank-Led Credit Line
MINNEAPOLIS – Vireo Growth Inc. announced it had received all required regulatory approvals and formally closed its acquisition of certain Colorado retail assets from PharmaCann Inc. Additionally, the company disclosed a senior secured asset-based revolving ...
Trulieve Reports Q2 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. released its second-quarter 2026 financial results, reflecting a period that included the deconsolidation of Harvest operations, recognition from TIME magazine, and the company's listing on the New York Stock Exchange. ...
NY Cannabis Market Gains New Outdoor Sales Path
NEW YORK – New York Governor Kathy Hochul signed legislation that expands the ways licensed microbusinesses and dispensaries can sell Cannabis products at approved community events. The measure aims to give smaller operators more direct ...
Germany Puts “GMP Washing” in Medical Cannabis on Notice
BERLIN – Germany's Hessian State Office for Health and Care (HLfGP) published a formal guidance document targeting the widespread practice of "GMP washing", i.e. importing Cannabis flowers from third-country cultivators under Good Agricultural and Collection ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered the most jam-packed period of meaningful news our sector has seen in 2026. Federal rescheduling hearings opened. Virginia finally locked in its retail framework. Definium posted the cleanest ...
Lazear Advises Medical Cannabis Company Organic Remedies on ESOP Transaction
COLUMBUS, Ohio, July 6, 2026 – Organic Remedies, one of Pennsylvania's leading medical cannabis companies, has completed its transition to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), marking another milestone in the ...
Q2 2026: The Quarter That Counted For Psychedelics
LOS ANGELES – Q2 2026 gave the psychedelic medicine sector the quarter that practitioners, investors, and regulators had been building up for years. Clinical programs delivered Phase 3 results, the White House signed an executive ...
Vireo Growth Closes Colorado Retail Deal, Secures Bank-Led Credit Line
MINNEAPOLIS – Vireo Growth Inc. announced it had received all required regulatory approvals and formally closed its acquisition of certain Colorado retail assets from PharmaCann Inc. Additionally, the company disclosed a senior secured asset-based revolving ...
Trulieve Reports Q2 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. released its second-quarter 2026 financial results, reflecting a period that included the deconsolidation of Harvest operations, recognition from TIME magazine, and the company's listing on the New York Stock Exchange. ...
NY Cannabis Market Gains New Outdoor Sales Path
NEW YORK – New York Governor Kathy Hochul signed legislation that expands the ways licensed microbusinesses and dispensaries can sell Cannabis products at approved community events. The measure aims to give smaller operators more direct ...
New Mexico Speeds Up Psilocybin Therapy Access
SANTA FE – State health leaders in New Mexico outlined plans this week to open a regulated psilocybin therapy program by the close of 2026, advancing the timeline a full year from the original statutory ...
Stiiizy Expands California Retail Network Buying 12 Gold Flora Outlets
LOS ANGELES – Stiiizy, the dominant player in California's Cannabis retail, has taken control of 12 former Gold Flora dispensaries in a $25 million court-approved transaction, marking a key step in the state's ongoing industry ...
Cronos Targets Europe Through Dutch Cannabis Leader Acquisition
TORONTO – Cronos Group Inc. has agreed to buy CanAdelaar B.V., the top supplier in the Netherlands' controlled adult-use Cannabis program, for $67 million upfront plus performance incentives. The move marks Cronos's first major step ...
Craft Cannabis Market Projects Steady Climb to $12.3B by 2031
LOS ANGELES – Small-scale producers in the Cannabis industry are gaining ground as buyers turn toward premium, handcrafted options, with the craft segment expected to double in value over the next five years. A report ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
Trulieve Clears $368M Debt with Full Redemption of Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up the buyback of its entire $368 million stack of 8% senior secured notes set to mature in 2026, handing over about $373 million in cash to cover the ...
OPINION: MJBizCon25 Review: The Race To Be Second
LAS VEGAS- Gosh… the MJBizCon I attended was awesome — genuinely one of the best and most productive ones I’ve ever been to — which is why I was so surprised to see how much ...
CRS Reveals Hemp Ban Enforcement Hurdles
WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...
Federal Hemp Overhaul Threatens Cannabis Seed Trade, Sparking Breeder Backlash
LOS ANGELES – A tucked-away clause in last month's federal spending package has upended the rules for Cannabis seeds, thrusting the U.S. genetics sector into uncertainty and prompting warnings from cultivators that prized strains could ...
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
Curaleaf Opens 70th Dispensary in Florida
STAMFORD – Curaleaf Holdings Inc. added its 70th medical Cannabis dispensary in Florida, targeting patients along the Space Coast with a new location in Cape Canaveral. The store, set for a grand opening on December ...
